Charlotte's Web Holdings (CWBHF) Liabilities and Shareholders Equity (2020 - 2026)
Charlotte's Web Holdings' (CWBHF) quarterly Liabilities and Shareholders Equity came in at $70.7 million in Q1 2026, down 34.56% year-on-year from $108.0 million in Q1 2025, and down 6.09% on a QoQ basis from $75.3 million in Q4 2025.
Charlotte's Web Holdings (CWBHF) Liabilities and Shareholders Equity (2020 - 2026) Analysis & Trends
Charlotte's Web Holdings (CWBHF) has 7 years of Liabilities and Shareholders Equity data on file, last reported at $70.7 million in Q1 2026.
- On a quarterly basis, Liabilities and Shareholders Equity fell 34.56% year-over-year to $70.7 million in Q1 2026; TTM through Mar 2026 was $315.5 million, a 32.99% decrease from a year earlier, with the FY2025 full-year figure at $75.3 million, down 33.65% from the prior year.
- Liabilities and Shareholders Equity for Q1 2026 stood at $70.7 million, down from $75.3 million in the prior quarter.
- Over the last five years, Liabilities and Shareholders Equity for CWBHF reached as high as $187.6 million in Q4 2022 and fell as low as $70.7 million in Q1 2026.
- Historically, Liabilities and Shareholders Equity has averaged $131.7 million across 5 years, with a median of $140.5 million in 2022.
- Across the five-year window, Liabilities and Shareholders Equity gained 16.62% in 2023 and plunged 34.56% in 2026, its largest moves.
- Year by year, Liabilities and Shareholders Equity stood at $187.6 million in 2022, then decreased by 18.7% to $152.5 million in 2023, then slipped by 25.64% to $113.4 million in 2024, then tumbled by 33.65% to $75.3 million in 2025, then declined by 6.09% to $70.7 million in 2026.
- Per Business Quant data, the three most recent Liabilities and Shareholders Equity figures were $70.7 million in Q1 2026, $75.3 million in Q4 2025, and $81.6 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 43.40 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 40.04 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 15.15 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 98.91 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 6.71 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 69.30 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 36.83 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 4.91 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 13.22 Bn |
| 10 | Charlotte's Web Holdings | 41.51 Mn | 36.32 Mn | 5.20 Mn | 70.69 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 70.69 Mn |
| Dec 31, 2025 | 75.27 Mn |
| Sep 30, 2025 | 81.60 Mn |
| Jun 30, 2025 | 87.98 Mn |
| Mar 31, 2025 | 108.02 Mn |
| Dec 31, 2024 | 113.44 Mn |
| Sep 30, 2024 | 119.64 Mn |
| Jun 30, 2024 | 129.79 Mn |
| Mar 31, 2024 | 141.78 Mn |
| Dec 31, 2023 | 152.55 Mn |
| Sep 30, 2023 | 163.87 Mn |
| Jun 30, 2023 | 176.59 Mn |
| Mar 31, 2023 | 175.97 Mn |
| Dec 31, 2022 | 187.64 Mn |
| Sep 30, 2022 | 140.52 Mn |
| Jun 30, 2022 | 153.01 Mn |
| Mar 31, 2022 | 160.82 Mn |
| Dec 31, 2021 | 171.51 Mn |
| Dec 31, 2020 | 310.79 Mn |